However, a recent study showed that daily intravenous selenium (1 mg Sel) in a cohort of COVID-19 patients with severe ARDS for a total of two weeks elevated their selenoprotein P and GPX3 levels [41]. The gene discussed is GPX3; the disease is COVID-19.